Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Axsome Therapeutics
Business Segments
Products & Services
Research And Development Expense
Research And Development Expense
Axsome Therapeutics
·
Products & Services
·
2 segments
·
Rolls up to
R&D
Breakdown
Segments
Balipodect
View metric
AZD7325
View metric
Quarterly
Annual
TTM
Segment
Q4 '25
Q1 '26
Balipodect
—
$10.4M
AZD7325
$2.3M
—
Total
$48.79M
$52.68M